Follow
Eduardo Latouche
Eduardo Latouche
Kytopen Corp.
Verified email at kytopen.com
Title
Cited by
Cited by
Year
Targeted cellular ablation based on the morphology of malignant cells
JW Ivey, EL Latouche, MB Sano, JH Rossmeisl, RV Davalos, ...
Scientific reports 5 (1), 17157, 2015
1132015
High-frequency irreversible electroporation for intracranial meningioma: a feasibility study in a spontaneous canine tumor model
EL Latouche, CB Arena, JW Ivey, PA Garcia, TE Pancotto, N Pavlisko, ...
Technology in cancer research & treatment 17, 1533033818785285, 2018
752018
The feasibility of a smart surgical probe for verification of IRE treatments using electrical impedance spectroscopy
M Bonakdar, EL Latouche, RL Mahajan, RV Davalos
IEEE Transactions on Biomedical Engineering 62 (11), 2674-2684, 2015
692015
Induction of rapid, reproducible hepatic ablations using next-generation, high frequency irreversible electroporation (H-FIRE) in vivo
IA Siddiqui, EL Latouche, MR DeWitt, JH Swet, RC Kirks, EH Baker, ...
Hpb 18 (9), 726-734, 2016
672016
Modeling of transmembrane potential in realistic multicellular structures before electroporation
T Murovec, DC Sweeney, E Latouche, RV Davalos, C Brosseau
Biophysical journal 111 (10), 2286-2295, 2016
572016
A comprehensive characterization of parameters affecting high-frequency irreversible electroporation lesions
T Miklovic, EL Latouche, MR DeWitt, RV Davalos, MB Sano
Annals of biomedical engineering 45, 2524-2534, 2017
552017
Irreversible electroporation for the ablation of pancreatic malignancies: A patient‐specific methodology
EL Latouche, MB Sano, MF Lorenzo, RV Davalos, RCG Martin
Journal of surgical oncology 115 (6), 711-717, 2017
522017
Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
RV Davalos, M Bonakdar, EL Latouche, RL Mahajan, JL Robertson, ...
US Patent 10,694,972, 2020
392020
High-frequency irreversible electroporation: Safety and efficacy of next-generation irreversible electroporation adjacent to critical hepatic structures
IA Siddiqui, RC Kirks, EL Latouche, MR DeWitt, JH Swet, EH Baker, ...
Surgical Innovation 24 (3), 276-283, 2017
342017
Method for treating neurological disorders, including tumors, with electroporation
E Latouche, S Lesko, L Epshteyn, B Christopher, JH Rossmeisl Jr, ...
US Patent 11,607,537, 2023
282023
Enhancing irreversible electroporation by manipulating cellular biophysics with a molecular adjuvant
JW Ivey, EL Latouche, ML Richards, GJ Lesser, W Debinski, RV Davalos, ...
Biophysical journal 113 (2), 472-480, 2017
262017
Induced cell morphology electroporation
JW Ivey, EL Latouche, SS Verbridge, RV Davalos, GJ Lesser, W Debinski
US Patent App. 16/340,106, 2020
252020
Simplified non-thermal tissue ablation with a single insertion device enabled by bipolar high-frequency pulses
MR DeWitt, EL Latouche, JD Kaufman, CC Fesmire, JH Swet, RC Kirks, ...
IEEE Transactions on Biomedical Engineering 67 (7), 2043-2051, 2019
162019
Treatment of infiltrative superficial tumors in awake standing horses using novel high-frequency pulsed electrical fields
CR Byron, MR DeWitt, EL Latouche, RV Davalos, JL Robertson
Frontiers in veterinary science 6, 265, 2019
112019
Modeling of irreversible electroporation treatments for the optimization of pancreatic cancer therapies
EL Latouche, RV Davalos, RCG Martin
6th European Conference of the International Federation for Medical and …, 2015
112015
Evaluation of next generation high-frequency irreversible electroporation (H-FIRE) for hepatic ablation in a swine model
I Siddiqui, E Baker, J Martinie, D Vrochides, R Swan, E Latouche, J Swet, ...
HPB 18, e288-e289, 2016
32016
In vivo study on the feasibility of a single needle electrode to perform irreversible electroporation (IRE) in hepatic tissue
E Latouche, M Dewitt, I Siddiqui, J Swet, R Kirks, E Baker, C Arena, ...
HPB 19, S104-S105, 2017
22017
Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
RV Davalos, M Bonakdar, EL Latouche, RL Mahajan, JL Robertson, ...
US Patent 11,903,690, 2024
12024
High frequency irreversible electroporation (H-FIRE) as a novel method of targeted cell death.
IA Siddiqui, RC Kirks, EH Baker, E Latouche, M Dewitt, J Swet, ...
Journal of Clinical Oncology 34 (4_suppl), 277-277, 2016
12016
Delivery of mRNA and CRISPR-Cas9 RNP to primary Natural Killer cells and T cells using the Flowfect ((R)), a new transfection technology
G Lewis, J Zhao, M Baladiang, D Reslow, A Hallinan, P Weinstein, ...
HUMAN GENE THERAPY 33 (23-24), A134-A134, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20